1. Home
  2. NCI vs ICU Comparison

NCI vs ICU Comparison

Compare NCI & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCI
  • ICU
  • Stock Information
  • Founded
  • NCI 1992
  • ICU 2018
  • Country
  • NCI Hong Kong
  • ICU United States
  • Employees
  • NCI N/A
  • ICU N/A
  • Industry
  • NCI
  • ICU Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCI
  • ICU Health Care
  • Exchange
  • NCI NYSE
  • ICU Nasdaq
  • Market Cap
  • NCI 10.1M
  • ICU 10.4M
  • IPO Year
  • NCI 2024
  • ICU N/A
  • Fundamental
  • Price
  • NCI $0.56
  • ICU $1.90
  • Analyst Decision
  • NCI
  • ICU
  • Analyst Count
  • NCI 0
  • ICU 0
  • Target Price
  • NCI N/A
  • ICU N/A
  • AVG Volume (30 Days)
  • NCI 352.1K
  • ICU 24.8K
  • Earning Date
  • NCI 12-19-2024
  • ICU 11-13-2024
  • Dividend Yield
  • NCI N/A
  • ICU N/A
  • EPS Growth
  • NCI N/A
  • ICU N/A
  • EPS
  • NCI 0.08
  • ICU N/A
  • Revenue
  • NCI $22,481,862.00
  • ICU $68,000.00
  • Revenue This Year
  • NCI N/A
  • ICU N/A
  • Revenue Next Year
  • NCI N/A
  • ICU $358.72
  • P/E Ratio
  • NCI $7.39
  • ICU N/A
  • Revenue Growth
  • NCI N/A
  • ICU N/A
  • 52 Week Low
  • NCI $0.35
  • ICU $1.50
  • 52 Week High
  • NCI $11.39
  • ICU $42.93
  • Technical
  • Relative Strength Index (RSI)
  • NCI N/A
  • ICU 64.59
  • Support Level
  • NCI N/A
  • ICU $1.55
  • Resistance Level
  • NCI N/A
  • ICU $1.78
  • Average True Range (ATR)
  • NCI 0.00
  • ICU 0.28
  • MACD
  • NCI 0.00
  • ICU 0.07
  • Stochastic Oscillator
  • NCI 0.00
  • ICU 50.00

About NCI NEO-CONCEPT INTL GRP HLDGS LTD

Neo-Concept International Group Holdings Ltd is a company whose a one-stop apparel solution services provider. It offers a full suite of services in the apparel supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management serving customers located in the European, and North American markets through Neo-Concept HK.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: